INDOCO REMEDIES LTD (India) holds 21 active US FDA Type II Drug Master Files and 3 inactive, has DMF or CEP filings on record for 25 active ingredients and is linked to 2 FDA-registered manufacturing sites. 8 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “INDOCO REMEDIES LTD: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/indoco-remedies-ltd

Overview

INDOCO REMEDIES LTD is an active pharmaceutical ingredient (API) supplier with 21 active FDA Type II Drug Master Files, covering ALLOPURINOL USP; ALOGLIPTIN BENZOATE; APIXABAN; ARIPIPRAZOLE USP; BESIFLOXACIN HYDROCHLORIDE; BETAXOLOL HYDROCHLORIDE USP.

Core services & business areas

API Manufacturing

Active ingredients with DMF or CEP filings

Substances for which INDOCO REMEDIES LTD holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

INDOCO REMEDIES LTD holds 21 active (24 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • RIVAROXABAN USPActive2022-11-10
  • LACOSAMIDE USP (PROCESS II)Active2022-03-17
  • METOPROLOL SUCCINATE USPActive2020-09-24
  • ARIPIPRAZOLE USPActive2019-07-03
  • NEOSTIGMINE METHYLSULFATE USPActive2016-11-30
  • CANAGLIFLOZINActive2016-10-18
  • APIXABANActive2016-07-20
  • ALOGLIPTIN BENZOATEActive2016-06-30
  • LACOSAMIDE USPActive2015-07-10
  • BESIFLOXACIN HYDROCHLORIDEActive2015-07-07
  • FEBUXOSTAT HEMIHYDRATE (FORM G)Active2015-02-11
  • BRINZOLAMIDE USPActive2014-04-02
  • RASAGILINE MESYLATEActive2013-11-12
  • BETAXOLOL HYDROCHLORIDE USPActive2011-09-22
  • BROMFENAC SODIUMActive2011-08-18
  • OLOPATADINE HYDROCHLORIDE USPActive2010-08-27
  • DORZOLAMIDE HYDROCHLORIDE USPActive2010-05-05
  • GLIMEPIRIDE USPActive2009-01-12
  • DICYCLOMINE HYDROCHLORIDE USPActive2008-12-04
  • BRIMONIDINE TARTRATE USPActive2008-10-29
  • ALLOPURINOL USPActive2008-01-15
  • QUETIAPINE FUMARATEInactive2011-10-14
  • CIPROFLOXACIN HYDROCHLORIDE USPInactive2008-08-11
  • Metformin Hydrochloride USP, as maufactured in Raigad District, INDIAInactive2007-12-05

Registered manufacturing sites (2)

Physical sites registered with the US FDA and resolved to INDOCO REMEDIES LTD, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

8 FDA enforcement records linked to this company.

  • warning_letter2024-12-16

    FDA Warning Letter (drug product)

  • 4832023-02-28

    Environmental Monitoring System

  • 4832023-02-28

    Scientifically sound laboratory controls

  • 4832023-02-28

    Procedures for sterile drug products

  • 4832023-02-28

    Equipment to control conditions

  • 4832018-11-21

    Procedures not in writing, fully followed

  • 4832018-11-21

    Complaint Handling Procedure

  • warning_letter2017-03-31

    FDA Warning Letter (drug product)

For suppliers

Is this INDOCO REMEDIES LTD?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.